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The intestine and the gut-associated lymphoid tissue (GALT) are essential components of whole body immune
defense, protecting the body from foreign antigens and pathogens, while allowing tolerance to commensal
bacteria and dietary antigens. The requirement for protein to support the immune system is well established. Less
is known regarding the immune modifying properties of individual amino acids, particularly on the GALT. Both oral
and parenteral feeding studies have established convincing evidence that not only the total protein intake, but the
availability of specific dietary amino acids (in particular glutamine, glutamate, and arginine, and perhaps
methionine, cysteine and threonine) are essential to optimizing the immune functions of the intestine and the
proximal resident immune cells. These amino acids each have unique properties that include, maintaining the
integrity, growth and function of the intestine, as well as normalizing inflammatory cytokine secretion and
improving T-lymphocyte numbers, specific T cell functions, and the secretion of IgA by lamina propria cells. Our
understanding of this area has come from studies that have supplemented single amino acids to a mixed protein
diet and measuring the effect on specific immune parameters. Future studies should be designed using amino acid
mixtures that target a number of specific functions of GALT in order to optimize immune function in domestic
animals and humans during critical periods of development and various disease states.
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MucosaIntroduction
It is well established that protein deficiency suppresses the
immune response and increases susceptibility to infection.
In fact, protein energy malnutrition is hypothesized to be
the leading contributor to immune deficiency globally [1].
Although the requirement for protein to support immunity
is well defined and part of current recommendations, only
recently have investigators begun to explore the potential
use of individual dietary amino acids to optimize immune
function. Early evidence suggested that amino acids are im-
portant energy substrates for immune cells [2-5] and for
antioxidant defense mechanisms [6]. There are also critical
health states (i.e. burns, trauma, infection, total parenteral
(TPN) feeding) or periods of development (i.e. weaning,
pregnancy) where it is now accepted that some dietary
non-essential amino acids become conditionally essential.* Correspondence: cjfield@ualberta.ca
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reproduction in any medium, provided the orThese include arginine, glutamine, glutamate, glycine, pro-
line, taurine and cysteine [7]. This change in need for these
amino acids in the diet may be due in part because of their
effects on immune function.
The intestine serves not only as the main site of nutrient
absorption and amino acid metabolism, but is also the lar-
gest immune organ in the body. The intestinal epithelium,
while facilitating nutrient absorption, also has a major role
in protecting the host from oral pathogens, inducing oral
tolerance and maintaining a healthy interaction with com-
mensal bacteria. Indeed both protein and single amino acid
deficiencies have been shown to impair the physical integ-
rity and growth of the intestinal epithelium, as well as alter
the immune response [8]. This manuscript will review our
current understanding of Gut- Associated Lymphoid Tissue
(GALT) and examine the immunomodulatory effects of
specific amino acids on immunity that occurs or originates
in the intestine.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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GALT, the largest immune organ in the body of humans
and domestic animals, contains a variety of immune cell
types from the innate and acquired immune systems
(as reviewed by [9]). Because of the proximity to the
microbiome and the immediate contact with food, it is
continually exposed to both ‘normal’ and potentially dan-
gerous antigens. Accordingly, GALT develops in a manner
that allows non-pathogenic substances, such as com-
mensal bacteria, to survive and enables tolerance to food
antigens, while protecting the host from pathogenic or-
ganisms and other potentially toxic substances [9]. GALT
is considered a component of the mucosal immune system
and is composed of aggregated tissue including Peyer’s
patches (PPs) and solitary lymphoid follicles, and non-
aggregated cells in the lamina propria, intestinal epithelial
cells (IECs), intraepithelial lymphocytes (IELs), as well as
mesenteric lymph nodes (MLNs) [9]. Collectively, GALT
plays a critical role in the development of the systemic im-
mune response. As a primary site of antigen exposure it
primes naïve T- and B-lymphocytes that develop into ef-
fector cells which migrate from the intestine to other sites
of the body to protect against immune challenges, such as
invading pathogens (Figure 1).
GALT has an important role in first line mucosal de-
fenses. The epithelium is protected from large pathogens
or particles by a layer of mucin, a glycoprotein secreted
from the specialized goblet cell within the endothelium
[10]. The IELs are dispersed among the IECs that line
intestinal villi and both cell types play a role in gutFigure 1 Diagram of the Gut-Associated Lymphoid Tissue.immune function (Figure 1). Tight junction proteins, such
as claudin, occludin and ZO-1, determine the mucosal
permeability and regulate the flow of solutes between the
IECs [10]. IECs are involved in the intestinal immune re-
sponse and some consider them an integral part of GALT.
They can activate or suppress IELs via secretion of anti-
microbial peptides, cytokines and chemokines or through
the processing and presentation of antigen in the context
of MHC Class I and MHC class II molecules to the IELS
[11]. IELs are primarily T-cells but have functions distinct
from peripheral T-cells [12]. The types of T-cells present
vary widely by species and disease states [13], but the ma-
jority are CD8+, CD45RO + (antigen mature), and express
adhesion molecules that are thought to be homing signals
[12]. In mice and cows/calves, but not humans, the major-
ity of T-cells are γδ T-cell Receptor + (TCR+) and the
remainder are αβTCR + [13-15]. The primary role of
γδTCR + cells is to induce tolerance and the primary role
of the αβTCR + cells is to induce IgA production [13]. The
difference between species may be related to the degree of
exposure to the microbiota and different dietary exposure
and requirements.
The PPs are lymphoid aggregates that line the intestine
and colon and are the primary inductive sites of the mu-
cosal humoral immune response (Figure 1) [16]. The
follicle associated epithelium (FAE) layer of the PP con-
tains highly specialized cells called microfold or M cells
that continually sample the intestinal contents bringing
them in contact with the resident immune cells (primar-
ily B-cells and small numbers of macrophages, dendritic
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through the intestinal epithelial cells to directly sample
antigen [18]. Antigen presenting cells, particularly den-
dritic cells, migrate from the PP or epithelium to the
MLN where they educate naïve T-cells [19]. The MLNs
act as the interphase between the peripheral immune
system and the gut and it is believed that they are the
primary sites of oral tolerance induction [17]. Oral toler-
ance is mechanistically defined as the process by which
dendritic cells present peptides to CD4+ T-cells and
through a series of signals (cell surface and secreted) in-
duce regulatory T-cells and subsequently the tolerance
to the antigen/peptide. In rats, MLN are composed pri-
marily of T-helper cells (55%), but also contain cytotoxic
T-cells (15%), B-cells (25%) and dendritic cells (5%) [20].
Pigs have slightly different phenotypes, with approxi-
mately 12% CD4+ CD8+, 25-28% CD4+ (single positive),
27-32% CD8+ (single positive) [21] and the rest com-
posed of B-cells and other antigen presenting cells [22].
After exposure to antigen in the PPs and MLNs, im-
mune cells circulate in the periphery and migrate to
other mucosal effector sites and home back to the lam-
ina propria (Figure 1) [23]. This is the major effector
component of GALT as these cells are antigen mature
and primed to respond to foreign antigens. The lamina
propria is comprised primarily of IgA secreting plasma
cells and effector T-cells (50% T-helper and 30% cyto-
toxic T-cells) [24]. Secretory IgA (sIgA) is the most
abundant immunoglobulin in the mammalian intestine
and acts by binding pathogens and facilitating the en-
trapment in mucous and removal from the intestinal
track [25]. Indeed a deficiency or inability to produce
IgA results in frequent intestinal infections [26].Amino acids and the immune system
Although it has long been established that adequate nutri-
tion is essential to the development and maintenance of
the immune system, there is a rapidly growing body of lit-
erature that demonstrates the immune benefits of supple-
mentation with specific nutrients, particularly during
critical stages of development or disease states, when ani-
mals may have a higher demand for essential and non-
essential nutrients. Such states include weaning, infectious
diseases or chronic inflammatory conditions. The import-
ance of individual amino acids to gut function and immun-
ity has become apparent in recent years due to studies that
have supplemented amino acids to animals/humans fed: 1)
intravenously (total parenteral nutrition(TPN)), which
demonstrates not only the importance of GALT but also
the importance to immune functions beyond the intestine;
2) during weaning, which demonstrates the importance of
these amino acids to the normal growth and development
of the intestine and GALT; and 3) during infection orchronic inflammation, which has demonstrated the role in
regulating inflammation and infectious challenges.
Glutamine
Glutamine has been the most extensively studied amino
acid with regards to its effects on GALT and the intestine.
In health, glutamine is categorized as a non-essential
amino acid and represents the amino acid in highest pro-
portions in the body. However, during periods of stress
and during critical stages of development the essentiality
of exogenous sources of glutamine is now well-established
to support growth [7] and health in young animals [27].Role as a precursor and energy substrate for immune and
epithelial cells
Glutamine is an important energy substrate and precursor
for other amino acids and derivatives in immune cells and
enterocytes (Table 1) [2-4,28]. In fact, both cell types cannot
function without at least some exogenous glutamine [29].
In immune cells, particularly lymphocytes, neutrophils and
macrophages, glutamine is used rapidly and metabolized
to glutamate, aspartate, lactate and CO2. Wu et al. [30]
demonstrated the main metabolic fates of glutamine in
enterocytes from weaning piglets are ammonia, glutamate,
alanine, aspartate and CO2. As a precursor for glutamate,
glutamine facilitates the production of glutathione (GSH),
an important regulator of redox in enterocytes and lympho-
cytes [31]. It also provides nitrogen for the synthesis of nu-
cleic acids and proteins that are needed for lymphocytes to
proliferate and produce signals such as cytokines [32].
Effects on intestinal function
In addition to its role as an energy substrate, glutamine
is important for intestinal development and function, in-
cluding maintaining the integrity of the gut barrier, the
structure of the intestinal mucosa and redox homeosta-
sis (Table 1).
Experimental evidence suggests that glutamine supple-
mentation to weaning animals is beneficial to intestinal
health. Wu et al. [28] first demonstrated that oral supple-
mentation with 1% w/w glutamine prevented the decrease
in jejunal villus height that occurs following weaning. Oral
supplementation of glutamine (0.5-1.0% w/w) to healthy
weaning piglets improves measures of intestinal health, in-
cluding increasing villus height and crypt depth, reducing
oxidative stress, lowering the proportion of apoptotic IECs
and increasing the proliferative rates of IECs [33,34]. Glu-
tamine supplementation has been demonstrated to reduce
the adverse effects of TPN on intestinal function in
healthy animals. A TPN solution containing 2% w/v glu-
tamine has improved villus length, crypt depth, tight junc-
tion protein expression (occludin, JAM1 and ZO-1), and
epithelial permeability [35-37].
Table 1 Summary of the role of amino acids in GALT and the intestine
Amino acid Functions
Glutamine • Oxidative substrate for immune cells and IECs
• Precursor for glutamate/GSH
• Intestinal growth, structure and function (young animals and disease states)
• Supports proliferative rates and reduces apoptosis of IECs
• Protects against E.coli/LPS-induced damage to intestinal structure and barrier function
• Lowers inflammatory and increases immunoregulatory cytokine production
• Improves the proliferative responses of IELs and MLN cells
• Intestinal IgA levels
• Increases lymphocyte numbers in PP, lamina propria and IELs
Glutamate • Oxidative substrate for immune cells and IECs
• Precursor for GSH and other amino acids (i.e. arginine)
• Intestinal growth, structure and function
• Acts as Immunotransmitter between dendritic cells and T-cells*
• Facilitates T-cell proliferation and Th1 and proinflammatory cytokine production
Arginine • Precursor for NO and glutamate in IECs and immune cells
• Intestinal growth, structure and function
• Supports microvasculature of intestinal mucosa
• Increases expression of HSP70 to protect intestinal mucosa
• Protects against E.coli/LPS-induced damage to intestinal structure and barrier function
• Facilitates neutrophil and macrophage killing through iNOS-mediated NO production
• Increases intestinal IgA levels
• Lowers inflammatory cytokine levels in intestine
• Increases T-lymphocytes in lamina propria, PPs, intraepithelial spaces
Methionine &
Cysteine
• Precursor for GSH, taurine and cysteine
• Reduces intestinal oxidative stress
• Intestinal structure
• Increases goblet cells and proliferating crypt cells
• Protects against DSS-induced intestinal damage (colitis model) by lowering inflammation, crypt damage and intestinal permeability.
Threonine • Mucin synthesis
• Intestinal structure and function
• Intestinal IgA levels
*No direct evidence of effects on immune cells in GALT.
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we and others have demonstrated that glutamine supple-
mentation may be protective to intestinal health during
E. coli infection in animals at weaning (Table 1). We previ-
ously demonstrated that supplementing the weaning diet
of piglets with glutamine (at 4.4% w/w) improved intes-
tinal barrier function (decreased ion movement across
mucosa), and maintained tight junction (claudin-1 and
occludin) protein expression after an E. coli challenge [38].
Similarly, Yi et al. [39] reported that weaned piglets
fed 2% w/w glutamine for 12 days prior to oral E. coli
challenge maintained villus height, area and volume simi-
lar to uninfected piglets. Suckling piglets supplemented
with oral glutamine (3.42 mmol/kg body weight) wereprotected against LPS-induced damage to the intestine
[40]. Glutamine supplementation (5% w/w) was also
reported to improve gut barrier function in a rat model of
colitis [41].
Effects on GALT
In vitro and in vivo studies have demonstrated the im-
portance of glutamine to B- and T-lymphocyte, neutro-
phil and macrophage functions (as reviewed by [42]). In
vitro, glutamine supports the proliferative response of T-
cells, plasma cell generation, macrophage inflammatory
cytokine production and phagocytosis of neutrophils and
macrophages [42]. We and others have shown that glu-
tamine supplementation lowers inflammatory cytokine
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increases immunoregulatory cytokine concentrations
and increases the proliferative responses of MLN cells
to a B- and T-cell mitogen (pokeweed mitogen) in healthy
weaning piglets [22,34,38,43]. We also reported a lower
proportion of IgA + cells in the MLN of weaning piglets fed
glutamine relative to the control group, suggestive of
less intestinal permeability and subsequently lower MLN
lymphocyte activation with supplementation (Table 1) [22].
In addition to healthy weaning animals, there is sup-
port for a protective effect of glutamine in models of
sepsis suggesting a therapeutic role for this amino acid
in the infected animal (Table 1). Oral glutamine supple-
mentation (1.1-2% w/v) prior to the induction of sepsis
or endotoxemia increased the number of lymphocytes
in PPs and lamina propria and normalized intestinal
IgA levels of control animals [44-46]. Interestingly, even
a single IV bolus of glutamine given immediately fol-
lowing the induction of sepsis appears to be protective.
Previous studies have demonstrated that a 0.75 g/kg
bolus of glutamine normalized systemic and intestinal
inflammatory cytokine levels, increased the number of
CD8αα +TCRαβ + and TCRγδ+/CD8αα + IELs , lowered
the expression of inflammatory mediators in IELs and
reduced IEL apoptosis [47,48]. Glutamine supplementa-
tion (4% w/w) also increased the proportion of IgA +
cells in the lamina propria in rat models of short bowel
syndrome [49].
The importance of glutamine to the intestine is also
evident when provided systemically. In healthy mice, a
TPN solution containing 2% w/v glutamine was re-
ported to restore intestinal IgA levels, the total number
of lymphocytes in PPs, IEL and lamina propria, and
improved intestinal levels of regulatory cytokines, IL-
10 and IL-4 [37,50,51].
Summary
Overall, animal studies have demonstrated that dietary
supplementation with glutamine (0.5%–5% w/w) is re-
quired to maintain a healthy intestinal mucosa and sup-
port several GALT functions during weaning (lymphocyte
counts and proliferative responses, decreased inflamma-
tory cytokine production and increased immunoregulatory
cytokines), infection (increased lymphocytes and sIgA
levels, decreased inflammatory cytokine levels and IEL
apoptosis, intestinal barrier function and structure and
IEL proliferation and decreased oxidative stress) and other
intestinal inflammatory states (increased sIgA levels).
Providing glutamine systemically (TPN studies) have
established the importance of glutamine to the health of
the intestinal barrier (maintained intestinal structure and
function) and for some GALT and other mucosal immune
responses (maintained sIgA, lymphocyte and regulatory
cytokine levels).Glutamate
Glutamate is one of the most abundant dietary amino
acids, but is found in very low concentrations in plasma
[6,52]. This is likely the result of glutamate being a major
energy substrate for intestinal epithelial cells [6]. It also
serves as a precursor for other amino acids (L-alanine, L-
aspartate, L-ornithine and L-proline) and for GSH in the
intestine [53]. GSH is essential to maintaining the thiol
redox state, which is vital to adequate functioning of
enterocytes and immune cells (Table 1) [6].
Effects on intestinal function
Glutamate has a very low capacity to cross biological
membranes, and enterocytes contain glutamate trans-
porters in the plasma membrane [54] making them one of
the few cells that can rapidly transport and metabolize ex-
ogenous glutamate [55]. This contributes to glutamate’s
recognition as the single most important oxidative sub-
strate for IECs [55]. Dietary glutamate, as both a carbon
and nitrogen donor, is the precursor of the conditionally
essential amino acid, arginine [55]. Maintaining endogen-
ous arginine synthesis in piglet enterocytes has been dem-
onstrated to be essential for optimal growth [31].
In vitro and in vivo studies have reported that providing
glutamate can modulate the intestinal epithelium (Table 1).
In an in vitro model of intestinal hyperpermeability (Caco2
cells), glutamate treatment reduced hyperpermeabilty up
to 30% [56]. Wu et al. [57] reported that weanling piglets
fed 1% w/w dietary glutamate for 20 days had increased je-
junal villus height, mucosal thickness and intestinal epi-
thelial cell proliferation. Although the immune functions
of the intestine were not specifically measured in these
studies, these changes would be consistent with improved
intestinal immune function. However, Tsuchioka et al.
[58] reported that rats given TPN supplemented with glu-
tamate (6.3% w/v) for 5 days had lower mucosal thickness
and villous height in the small intestine relative to control
TPN, suggesting a negative effect on the intestinal epithe-
lium when glutamate is provided systemically.
Effects on immune function and GALT
Although immune cells produce considerable amounts of
glutamate when provided glutamine [4], investigations into
the effects of glutamate on immune cells are limited. It has
been recently reported that T-cells, B-cells, dendritic cells
and macrophages express glutamate receptors [59,60],
suggesting that glutamate likely has an important role in
immune cell function. In support, Sturgill et al. [60]
reported that purified B-cells and peripheral mononuclear
cells produced more IgG and IgE when cultured with glu-
tamate in vitro. In T-cells, glutamate may function as an
immunotransmitter, akin to its role as a neurotransmitter,
as extracellular concentrations of glutamate have been
shown to regulate T-cell responses (Table 1). Pacheco et al.
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during antigen presentation to T-cells and this released
glutamate influences T-cell proliferation and cytokine pro-
duction. During the early stages of dendritic cell-T-cell
interaction, glutamate binds to the constitutively expressed
mGlu5R on T-cells to inhibit proliferation and cytokine
production; however, later in the interaction glutamate
binds to mGlu1R to induce T-cell proliferation and Th1
and proinflammatory cytokine production [61]. This study
demonstrates that glutamate plays an essential role in regu-
lating antigen-specific T-cell activation and suggests that
the high concentrations of glutamate in the intestine may
play an important role in T-cell regulation in the gut.
Despite glutamate being present in high concentrations
in the intestinal lumen and immune cells having unique
glutamate receptors, there have not been dietary studies
that have directly assessed the effect on GALT. Due to the
high oxidation rate of glutamate by enterocytes and im-
mune cells, and its role as a precursor for GSH and other
amino acids [62] it is reasonable to postulate that changes
in the availability of glutamate modulates aspects of GALT
(Table 1). We recently reviewed the evidence and pre-
sented a hypothesis for a novel role of glutamate receptors
on immune cells as the means by which changes in glu-
tamate availability modulates specific immune functions
[6]. In that review, we proposed that due to its immuno-
suppressive effects at concentrations above plasma levels,
glutamate may have a key role in the development and
maintenance of oral tolerance [6], a unique aspect of im-
munity in the intestine.
Despite the lack of investigation into the immune
modulating properties of glutamate on GALT, it is likely
that it has an essential role. To date, the effects of glu-
tamate on GALT have not been examined in vivo. How-
ever, it is likely that glutamate has an essential role as an
oxidative substrate to both enterocytes and immune
cells. It is also a precursor for the synthesis of GSH,
which is required to protect the intestinal mucosa and
optimize immune cell function. And, finally, glutamate is
a precursor for arginine, the substrate for the synthesis
of NO. A high rate of NO synthesis by neutrophils is re-
quired during the innate immune response to infection.
This is an important role of the immune system in the
intestine.
Summary
Dietary glutamate appears essential for intestinal barrier
function and likely other immune functions of the IEC, pri-
marily as a precursor for GSH and as an oxidative sub-
strate for enterocytes. Based on the available data, we can
only hypothesize that the availability of glutamate to the
cells in GALT has an immunoregulatory role. Studies
conducted in systemic immune cells suggest that glutamate
is essential for T-cell activation and B-cell immunoglobulinproduction and we postulate from indirect evidence that
glutamate has a role in the induction of oral tolerance
(that originates in GALT) and protection from enteric
infections.
Arginine
In most adult mammals, arginine is considered a dietary
non-essential amino acid as it can be synthesized from
glutamine, glutamate and proline, but becomes condition-
ally essential during periods of stress [63,64]. Moreover,
the absence of arginine in the diet has been shown to have
adverse effects in adults, including reproductive, metabolic
and neurological derangements [29]. Arginine is classified
as an essential amino acid in young mammals as endogen-
ous synthesis cannot meet demands [29]. Several studies
have demonstrated that arginine supplementation, either
to the piglet’s diet or to the lactating sow, improves growth
performance in piglets [65-68]. The immune system is
particularly sensitive to changes in arginine availability
during early development and various disease states.
Metabolism
Arginine is the most plentiful nitrogen carrier in animals
and is a precursor for urea, polyamines, proline, creatin-
ine, agmatine, glutamate and protein [64]. Perhaps most
importantly, for the immune system, arginine is the only
precursor for nitric oxide synthase (all isoforms) for the
synthesis of nitric oxide (NO). In both the intestine and
immune system, NO is essential for optimal functioning,
including regulating the inflammatory response, facilitat-
ing killing of microbes by neutrophils and macrophages,
and facilitating lymphocyte functions [63].
Effects on intestinal function
The structure and function of the intestine is sensitive to
the amount of arginine in the diet during critical periods
of development and disease states (Table 1). Studies have
shown that arginine supplementation supports the growth
and the development of the intestine and mucosal barrier
in weanling piglets [65,69,70]. Dietary L-arginine supple-
mentation ranging from 0.6% to 1.0% w/w increased intes-
tinal growth, mucosa microvasculature (0.7% but not 1.2%
w/w), villus height, crypt depth, and goblet cell counts in
the piglets [65,69,70]. A proposed mechanism is that feed-
ing arginine (0.6% w/w) increases expression of heat shock
protein 70 (HSP70) which prevents protein denaturation
and associated cellular stress [65].
In addition to supporting normal growth and develop-
ment, supplementation with arginine has also been re-
ported to reduce intestinal damage induced by E. coli
derived LPS (Table 1). Sukhotnik et al. [71] demonstrated
that arginine (2% w/v in drinking water) ameliorated the
adverse effects of LPS on the rat intestine, including im-
proving intestinal weight, villous height, epithelial cell
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arginine (0.5 or 1.0% w/w) supplemented to weaned piglets
abolished the villous atrophy and morphological changes
induced by LPS infection [72]. Arginine supplementation
(1% v/v in water) lowered serum concentrations of endo-
toxin suggestive of improved gut permeability in a rat
model of acute pancreatitis [73]. In support of this finding,
other researchers have reported that arginine supplementa-
tion reduces bacterial counts in mesenteric lymph nodes
(4% w/w arginine) [74] and improves gut barrier function
(0.33 g/d arginine) [75].
Effects on GALT
The immunomodulatory properties of L-arginine are
well established and have been reviewed elsewhere
[63,76,77]. Arginine has a fundamental role in both the
innate and adaptive immune responses. One of the pri-
mary functions of arginine in leukocytes is as a substrate
for inducible nitric oxide synthase (iNOS) to produce
NO. Macrophages and neutrophils utilize NO to kill a
variety of pathogens and malignant cells [63,76]. NO
also appears to be important for B-cell development and
T-cell receptor function [63]. The effects of arginine on
GALT have been studied in both healthy and disease
states and the available evidence suggest a beneficial ef-
fect on immune function.
Feeding arginine has been shown to be beneficial to
GALT in inflammatory and trauma animal models, as
well as healthy animals (Table 1). Rats fed diets
containing 1% w/w arginine orally prior to the induction
of acute pancreatitis had a higher proportion of T-helper
cells and an increased ratio of CD4+:CD8+ cells in the
intestinal lamina propria, as well as a greater concentra-
tion of fecal sIgA [73]. Similarly, Fan et al. [78] reported
that supplementing arginine (1 g/kg) to severely burned
mice for 7 days increased the number of lymphocytes
isolated from PPs and intestinal IgA concentrations. Ar-
ginine supplemented mice (1 g/kg) also had intestinal
cytokine profiles favouring a less inflammatory state (in-
creased IL-4 and IL-10 and lower IFN-γ and IL-2) [78]. In
chickens, feeding diets containing 2% w/w arginine im-
proved intraepithelial cytotoxicity to viral infection and im-
proved the antibody response to vaccine, suggesting effects
on both cell types of the acquired immune system [79].
Animal models of TPN in both health and disease states
have demonstrated that arginine supplementation can re-
verse the negative effects that TPN (not providing nutri-
ents to the intestine) has on GALT. Mice supplemented
with arginine (2 g/kg), prior to (oral diet) and following
(TPN), had greater numbers of PPs and lymphocytes iso-
lated from PPs, higher intestinal IgA levels and greater
PHA-stimulated IL-10 production (splenocytes) relative to
mice given no arginine prior to induction of sepsis [80].
This study suggests that dietary arginine may be essentialto maintaining the intestinal immune system during acute
infection. Despite these improvements in immune param-
eters, arginine supplementation in this model of sepsis did
not significantly improve survival [80]. However, arginine
supplementation to healthy animals fed by TPN also
seems to have a similar beneficial effect on GALT. TPN
supplemented with 1% w/v arginine given to healthy mice
increased the proportion of αβTCR+ T-cells and CD4+ T-
cells in PPs and intraepithelial spaces compared to mice
supplemented with 0.3% w/v arginine [81]. These studies
strongly support an essential role for a systemic supply of
arginine to maintaining GALT, particularly when the in-
testine is not receiving nutrients directly from the diet.
Summary
There is considerable support that in health and stressed
conditions oral ingestion of arginine (0.6% to 2% w/w) has
a beneficial effect on GALT, with particular improvements
in aspects of the acquired immune response. Arginine also
supports the growth, development and maintenance of a
healthy intestinal mucosa during critical periods of devel-
opment (weaning) and under certain health conditions.
These effects on the intestinal mucosa and GALT may be
partly explained by arginine’s role as an essential precursor
for NO.
Other amino acids
Methionine and cysteine–sulfur containing amino acids
The dietary essentiality of methionine and conditional es-
sentiality of cysteine to humans and animals has been well
established [82,83]. Currently, there is little direct evidence
demonstrating that these sulfur-containing amino acids
alter immune function. However, indirectly their efficacy
is supported by evidence that their metabolites (taurine,
GSH and homocysteine) have immunomodulatory proper-
ties in vitro [82]. GSH (also see glutamate section) func-
tions as a free radical scavenger and may support proper
immune cell function through a role in T-cell prolifera-
tion, and inflammatory cytokine regulation [6,82,83]. GSH
also has a crucial role in protecting the intestinal epithe-
lium from electrophile and fatty acid hydroperoxide dam-
age [29]. There is evidence that taurine and homocysteine
have immunodulatory properties. Taurine is an end prod-
uct of cysteine metabolism and diets devoid of taurine in
cats resulted in reduced lymphocyte numbers, and mono-
nuclear cells with impaired respiratory burst capacity [82].
In vitro evidence suggests that taurine chloramine can
suppress NF-kappaB activation and pro-inflammatory
cytokine (IL-6 and TNF-α) production and in stimulated
macrophages [82]. In an in vitro model, homocysteine
promoted monocyte activation and increased their adhe-
sion to endothelial cells [84]. At present there are no feed-
ing studies to provide direct support for the effect of
homocysteine or taurine on immune function in GALT.
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cysteine are important to ensure the health of the intestine
and immune function during development and in inflam-
matory states (Table 1). For example, Bauchart-Thevret
et al. [85] demonstrated that relative to healthy neonatal
piglets fed a deficient diet, piglets supplemented with cyst-
eine (0.25 g/kg) and methionine (25 g/kg) had less intes-
tinal oxidative stress, improved villus height and area and
crypt depth, higher number of goblet cells and Ki-67+
proliferative crypt cells. Cysteine also appears to be thera-
peutic in stressed inflammatory states, through improving
intestinal inflammation and permeability. An infusion of L-
cysteine (0.144 g/kg) given to pigs after DSS-induced colitis
lowered mRNA expression of IL-8, MCP-1, MIP-1α, and
MIP-2, and normalized IL-6, TNF- α, IFN-γ, IL-12, IL-1β
and IL-10 in colon tissue [86]. In addition, less inflamma-
tory cell infiltration, crypt damage and lower intestinal
permeability were observed in the pigs supplemented with
L-cysteine (Table 1) [86]. While these studies demonstrate
the importance of sulfur containing amino acids to gut
health in healthy and stressed animals, there is no direct
evidence of the effects on lymphocyte or macrophage cell
function in GALT.Threonine
Threonine is a dietary essential amino acid that has been
shown to have a particularly high retention rate in the
intestine, which suggests an important function in the
gut [55,87]. Threonine has a major role in mucin synthe-
sis, a glycoprotein that is required to protect the intes-
tinal epithelium (Table 1) [88]. Mucin production is
reduced in diets low or deficient in threonine in healthy
rats and piglets [88-91]. Feeding a diet low in threonine
(0.37% w/w) was found to adversely affect tight junction
ultrastructure in the intestinal epithelium and induce vil-
lus atrophy in pigs [91,92], supporting the importance of
a dietary supply of threonine in maintaining gut barrier
function. Consistent with this, threonine-deficient piglets
were found to have higher paracellular permeability
which would increase the risk of infectious organisms or
their products coming in contact with the body [92]. To
date, there are no studies examining the effect of feeding
threonine on the function of immune cells in GALT.
However, Hamard et al. [92] reported that pigs fed a
30%-reduced threonine diet for two weeks had increased
expression of genes involved in inflammation and im-
munity in the ileum, including MHC Class I antigen
(HLA-B), T-cell differentiation antigen CD6, and chemo-
kine receptors. Chickens fed 0.4% w/w threonine in the
diet for 8 weeks had higher IgA concentrations in the
ileum than chickens fed 0%, 0.1% or 0.2% threonine [93],
suggesting an effect on B cell function in the lamina
propria (Table 1).Conclusion
The intestine and the GALT are essential components of
immune defense, protecting the animal/human from for-
eign antigens and pathogens, while allowing the absorp-
tion and tolerance of dietary nutrients. Feeding trials,
primarily conducted in pigs and rodents, have established
convincing evidence that not only the total protein intake
but the availability of specific dietary amino acids, in par-
ticular glutamine, glutamate, and arginine, and perhaps
methionine, cysteine and threonine, are essential to opti-
mizing the immune functions of the intestine and specific
immune cells located in GALT. These amino acids modu-
late their effects by maintaining the integrity, growth and
immune functions of the epithelial cells in the intestine, as
well as improve T-cell numbers and function, the secre-
tion of IgA, and regulate inflammatory cytokine secretion.
The studies conducted using feeding regimes (TPN) that
bypass the oral route suggest that amino acids delivered in
the blood from other parts of the body are important for
maintaining GALT.
To date the majority of the studies have focussed on
modulating single amino acids in a diet that contains
many different proteins (combinations of amino acids)
and determined function by measuring selective (often
single parameters) functions. Evidence for some of these
immunoactive amino acids comes primarily from in vitro
studies or cells isolated from the systemic immune system
(blood). Future studies should be designed using amino
acid mixtures based on the existing knowledge to optimize
immune function and growth in domestic animals and
humans during critical periods of intestinal and GALT de-
velopment in order to optimize health.
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